


<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmacy Daily</title>
	<atom:link href="http://www.pharmacydaily.com.au/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmacydaily.com.au</link>
	<description>Australia&#039;s favourite pharmacy industry publication</description>
	<lastBuildDate>Wed, 19 Jun 2013 02:38:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Transparency bill review</title>
		<link>http://www.pharmacydaily.com.au/news/transparency-bill-review/25110</link>
		<comments>http://www.pharmacydaily.com.au/news/transparency-bill-review/25110#comments</comments>
		<pubDate>Wed, 19 Jun 2013 02:38:35 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[Headlines]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Senator Richard Di Natale]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25110</guid>
		<description><![CDATA[A SENATE Committee review of
the Therapeutic Goods Amendment
(Pharmaceutical Transparency)
Bill 2013 has recommended that
it not be passed, because it would
“significantly curtail legitimate
interactions between therapeutic
product suppliers and healthcare
professionals”.]]></description>
	A SENATE Committee review of
the Therapeutic Goods Amendment
(Pharmaceutical Transparency)
Bill 2013 has recommended that
it not be passed, because it would
“significantly curtail legitimate
interactions between therapeutic
product suppliers and healthcare
professionals”.			<content:encoded><![CDATA[A SENATE Committee review of
the Therapeutic Goods Amendment
(Pharmaceutical Transparency)
Bill 2013 has recommended that
it not be passed, because it would
“significantly curtail legitimate
interactions between therapeutic
product suppliers and healthcare
professionals”.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/transparency-bill-review/25110/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Business plan finals</title>
		<link>http://www.pharmacydaily.com.au/news/business-plan-finals/25115</link>
		<comments>http://www.pharmacydaily.com.au/news/business-plan-finals/25115#comments</comments>
		<pubDate>Wed, 19 Jun 2013 02:38:18 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Gold Cross]]></category>
		<category><![CDATA[lackmores]]></category>
		<category><![CDATA[National Student Business Plan]]></category>
		<category><![CDATA[PDL]]></category>
		<category><![CDATA[Pharmacy Business Network]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25115</guid>
		<description><![CDATA[TWELVE teams in the Pharmacy
Guild’s annual National Student
Business Plan competition have
been told they will proceed to the
quarter final round which will run
from 24 Jun-12 Jul.]]></description>
	TWELVE teams in the Pharmacy
Guild’s annual National Student
Business Plan competition have
been told they will proceed to the
quarter final round which will run
from 24 Jun-12 Jul.			<content:encoded><![CDATA[TWELVE teams in the Pharmacy
Guild’s annual National Student
Business Plan competition have
been told they will proceed to the
quarter final round which will run
from 24 Jun-12 Jul.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/business-plan-finals/25115/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>J&amp;J cancer move</title>
		<link>http://www.pharmacydaily.com.au/news/jj-cancer-move/25112</link>
		<comments>http://www.pharmacydaily.com.au/news/jj-cancer-move/25112#comments</comments>
		<pubDate>Wed, 19 Jun 2013 02:36:57 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Aragon Pharmaceuticals]]></category>
		<category><![CDATA[Dr Peter Lebowitz]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25112</guid>
		<description><![CDATA[JOHNSON &amp; Johnson has
announced the purchase
of privately held Aragon
Pharmaceuticals, which specialises
in the development of hormonally
based cancer treatments.]]></description>
	JOHNSON &amp; Johnson has
announced the purchase
of privately held Aragon
Pharmaceuticals, which specialises
in the development of hormonally
based cancer treatments.			<content:encoded><![CDATA[JOHNSON &amp; Johnson has
announced the purchase
of privately held Aragon
Pharmaceuticals, which specialises
in the development of hormonally
based cancer treatments.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/jj-cancer-move/25112/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MA coalition praise</title>
		<link>http://www.pharmacydaily.com.au/news/ma-coalition-praise/25111</link>
		<comments>http://www.pharmacydaily.com.au/news/ma-coalition-praise/25111#comments</comments>
		<pubDate>Wed, 19 Jun 2013 02:35:10 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Brendan Shaw]]></category>
		<category><![CDATA[Medicines Australia]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25111</guid>
		<description><![CDATA[MEDICINES Australia has hailed
a commitment by the Federal
opposition to reducing red tape
and providing policy certainty for
medical research in Australia as a
vital area of microeconomic reform.]]></description>
	MEDICINES Australia has hailed
a commitment by the Federal
opposition to reducing red tape
and providing policy certainty for
medical research in Australia as a
vital area of microeconomic reform.			<content:encoded><![CDATA[MEDICINES Australia has hailed
a commitment by the Federal
opposition to reducing red tape
and providing policy certainty for
medical research in Australia as a
vital area of microeconomic reform.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/ma-coalition-praise/25111/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MLE expo invitation</title>
		<link>http://www.pharmacydaily.com.au/news/mle-expo-invitation/25109</link>
		<comments>http://www.pharmacydaily.com.au/news/mle-expo-invitation/25109#comments</comments>
		<pubDate>Wed, 19 Jun 2013 02:34:54 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Making Life Easy]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25109</guid>
		<description><![CDATA[PHARMACY staff are reminded
to register for the upcoming
Making Life Easy expo, which
will showcase a full range of lift
chairs and scooters which can be
easily ordered without having to
physically keep them in stock.]]></description>
	PHARMACY staff are reminded
to register for the upcoming
Making Life Easy expo, which
will showcase a full range of lift
chairs and scooters which can be
easily ordered without having to
physically keep them in stock.			<content:encoded><![CDATA[PHARMACY staff are reminded
to register for the upcoming
Making Life Easy expo, which
will showcase a full range of lift
chairs and scooters which can be
easily ordered without having to
physically keep them in stock.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/mle-expo-invitation/25109/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TGA plans OTC ad reforms</title>
		<link>http://www.pharmacydaily.com.au/news/tga-plans-otc-ad-reforms/25107</link>
		<comments>http://www.pharmacydaily.com.au/news/tga-plans-otc-ad-reforms/25107#comments</comments>
		<pubDate>Wed, 19 Jun 2013 02:34:37 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[Headlines]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Mick O’Connor]]></category>
		<category><![CDATA[TGA]]></category>
		<category><![CDATA[Therapeutic Goods Administration]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25107</guid>
		<description><![CDATA[THE Therapeutic Goods
Administration has outlined
proposals to reform the current
“pre-approval” system for
advertisements for OTC products,
as well as improve the efficiency of
the complaints handling process.]]></description>
	THE Therapeutic Goods
Administration has outlined
proposals to reform the current
“pre-approval” system for
advertisements for OTC products,
as well as improve the efficiency of
the complaints handling process.			<content:encoded><![CDATA[THE Therapeutic Goods
Administration has outlined
proposals to reform the current
“pre-approval” system for
advertisements for OTC products,
as well as improve the efficiency of
the complaints handling process.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/tga-plans-otc-ad-reforms/25107/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dispensary Corner 18 Jun 13</title>
		<link>http://www.pharmacydaily.com.au/news/dispensary-corner-18-jun-13/25100</link>
		<comments>http://www.pharmacydaily.com.au/news/dispensary-corner-18-jun-13/25100#comments</comments>
		<pubDate>Tue, 18 Jun 2013 03:30:52 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[Dispensary Corner]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Raffael Medina Brochero]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25100</guid>
		<description><![CDATA[A POET from Colombia has placed
his own testicles up for sale, with
the aim of raising money for a
tour of Europe.]]></description>
	A POET from Colombia has placed
his own testicles up for sale, with
the aim of raising money for a
tour of Europe.			<content:encoded><![CDATA[A POET from Colombia has placed
his own testicles up for sale, with
the aim of raising money for a
tour of Europe.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/dispensary-corner-18-jun-13/25100/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Guild, PSA unite on CPD cap</title>
		<link>http://www.pharmacydaily.com.au/news/guild-psa-unite-on-cpd-cap/25099</link>
		<comments>http://www.pharmacydaily.com.au/news/guild-psa-unite-on-cpd-cap/25099#comments</comments>
		<pubDate>Tue, 18 Jun 2013 03:30:08 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[Headlines]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Grant Kardachi]]></category>
		<category><![CDATA[Kos Sclavos]]></category>
		<category><![CDATA[Pharmaceutical Society of Australia]]></category>
		<category><![CDATA[Pharmacy Guild]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25099</guid>
		<description><![CDATA[THE Pharmaceutical Society of
Australia and the Pharmacy Guild
have issued a joint statement about
their serious concerns over the
impact on professional standards of
the government’s proposed $2000
cap on self-education expenses.]]></description>
	THE Pharmaceutical Society of
Australia and the Pharmacy Guild
have issued a joint statement about
their serious concerns over the
impact on professional standards of
the government’s proposed $2000
cap on self-education expenses.			<content:encoded><![CDATA[THE Pharmaceutical Society of
Australia and the Pharmacy Guild
have issued a joint statement about
their serious concerns over the
impact on professional standards of
the government’s proposed $2000
cap on self-education expenses.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/guild-psa-unite-on-cpd-cap/25099/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Guild Priorities</title>
		<link>http://www.pharmacydaily.com.au/news/guild-priorities/25096</link>
		<comments>http://www.pharmacydaily.com.au/news/guild-priorities/25096#comments</comments>
		<pubDate>Tue, 18 Jun 2013 03:29:10 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[Guild Update]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25096</guid>
		<description><![CDATA[The Guild’s role is to advance
the interests of its community
pharmacy members and help
them deliver exceptional health
services to all Australians.]]></description>
	The Guild’s role is to advance
the interests of its community
pharmacy members and help
them deliver exceptional health
services to all Australians.			<content:encoded><![CDATA[The Guild’s role is to advance
the interests of its community
pharmacy members and help
them deliver exceptional health
services to all Australians.]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/guild-priorities/25096/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>APC fee to rise</title>
		<link>http://www.pharmacydaily.com.au/news/apc-fee-to-rise/25097</link>
		<comments>http://www.pharmacydaily.com.au/news/apc-fee-to-rise/25097#comments</comments>
		<pubDate>Tue, 18 Jun 2013 03:28:48 +0000</pubDate>
		<dc:creator>heather</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Australian Pharmacy Council]]></category>

		<guid isPermaLink="false">http://www.pharmacydaily.com.au/?p=25097</guid>
		<description><![CDATA[THE Australian Pharmacy Council
has advised that effective from 01
Jul its fee for the Initial Eligibility
Assessment and Skills Assessment
(for example for Australian/NZ
graduates) will increase to $700 per
application..]]></description>
	THE Australian Pharmacy Council
has advised that effective from 01
Jul its fee for the Initial Eligibility
Assessment and Skills Assessment
(for example for Australian/NZ
graduates) will increase to $700 per
application..			<content:encoded><![CDATA[THE Australian Pharmacy Council
has advised that effective from 01
Jul its fee for the Initial Eligibility
Assessment and Skills Assessment
(for example for Australian/NZ
graduates) will increase to $700 per
application..]]></content:encoded>
			<wfw:commentRss>http://www.pharmacydaily.com.au/news/apc-fee-to-rise/25097/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
